Table 3.
Evaluation of Outcomes Based on Grade and Stratified by Doubling Time
| Outcomes |
Low grade (n = 94) |
High grade (n = 21) |
||||
|---|---|---|---|---|---|---|
| Calcitonin doubling time | <2 Years | >2 Years | Never doubled | <2 Years | >2 Years | Never doubled |
| Disease status | ||||||
| Alive w/o disease | 0/6 | 12/23 | 55/65 | 2/20 | — | 0/1 |
| Alive with disease | 5/6 | 11/23 | 6/65 | 8/20 | 1/1 | |
| Dead with disease | 1/6 | 0/23 | 1/65 | 9/20 | 0/1 | |
| Dead other causes | 0/6 | 0/2 | 3/65 | 1/20 | 0/1 | |
| Locoregional recurrence | 2/6 | 4/23 | 6/65 | 15/20 | — | 1/1 |
| Distant recurrence | 1/6 | 11/23 | 1/65 | 10/20 | — | 1/1 |
| Mortality | 1/6 | 0/23 | 1/23 | 9/20 | — | 0/1 |